{"pmid":32308203,"title":"Patients with respiratory symptoms are at greater risk of COVID-19 transmission.","text":["Patients with respiratory symptoms are at greater risk of COVID-19 transmission.","Respir Med","Yang, Rongrong","Gui, Xien","Xiong, Yong","32308203"],"journal":"Respir Med","authors":["Yang, Rongrong","Gui, Xien","Xiong, Yong"],"date":"2020-04-21T11:00:00Z","year":2020,"_id":"32308203","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.rmed.2020.105935","keywords":["covid-19","cough","emerging infectious disease","virus shedding"],"source":"PubMed","topics":["Transmission","Diagnosis"],"weight":1,"_version_":1664632501443756032,"score":8.518259,"similar":[{"pmid":32259477,"pmcid":"PMC7144857","title":"Infection and Rapid Transmission of SARS-CoV-2 in Ferrets.","text":["Infection and Rapid Transmission of SARS-CoV-2 in Ferrets.","The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in China and rapidly spread worldwide. To prevent SARS-CoV-2 dissemination, understanding the in vivo characteristics of SARS-CoV-2 is a high priority. We report a ferret model of SARS-CoV-2 infection and transmission that recapitulates aspects of human disease. SARS-CoV-2-infected ferrets exhibit elevated body temperatures and virus replication. Although fatalities were not observed, SARS-CoV-2-infected ferrets shed virus in nasal washes, saliva, urine, and feces up to 8 days post-infection. At 2 days post-contact, SARS-CoV-2 was detected in all naive direct contact ferrets. Furthermore, a few naive indirect contact ferrets were positive for viral RNA, suggesting airborne transmission. Viral antigens were detected in nasal turbinate, trachea, lungs, and intestine with acute bronchiolitis present in infected lungs. Thus, ferrets represent an infection and transmission animal model of COVID-19 that may facilitate development of SARS-CoV-2 therapeutics and vaccines.","Cell Host Microbe","Kim, Young-Il","Kim, Seong-Gyu","Kim, Se-Mi","Kim, Eun-Ha","Park, Su-Jin","Yu, Kwang-Min","Chang, Jae-Hyung","Kim, Eun Ji","Lee, Seunghun","Casel, Mark Anthony B","Um, Jihye","Song, Min-Suk","Jeong, Hye Won","Lai, Van Dam","Kim, Yeonjae","Chin, Bum Sik","Park, Jun-Sun","Chung, Ki-Hyun","Foo, Suan-Sin","Poo, Haryoung","Mo, In-Pil","Lee, Ok-Jun","Webby, Richard J","Jung, Jae U","Choi, Young Ki","32259477"],"abstract":["The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in China and rapidly spread worldwide. To prevent SARS-CoV-2 dissemination, understanding the in vivo characteristics of SARS-CoV-2 is a high priority. We report a ferret model of SARS-CoV-2 infection and transmission that recapitulates aspects of human disease. SARS-CoV-2-infected ferrets exhibit elevated body temperatures and virus replication. Although fatalities were not observed, SARS-CoV-2-infected ferrets shed virus in nasal washes, saliva, urine, and feces up to 8 days post-infection. At 2 days post-contact, SARS-CoV-2 was detected in all naive direct contact ferrets. Furthermore, a few naive indirect contact ferrets were positive for viral RNA, suggesting airborne transmission. Viral antigens were detected in nasal turbinate, trachea, lungs, and intestine with acute bronchiolitis present in infected lungs. Thus, ferrets represent an infection and transmission animal model of COVID-19 that may facilitate development of SARS-CoV-2 therapeutics and vaccines."],"journal":"Cell Host Microbe","authors":["Kim, Young-Il","Kim, Seong-Gyu","Kim, Se-Mi","Kim, Eun-Ha","Park, Su-Jin","Yu, Kwang-Min","Chang, Jae-Hyung","Kim, Eun Ji","Lee, Seunghun","Casel, Mark Anthony B","Um, Jihye","Song, Min-Suk","Jeong, Hye Won","Lai, Van Dam","Kim, Yeonjae","Chin, Bum Sik","Park, Jun-Sun","Chung, Ki-Hyun","Foo, Suan-Sin","Poo, Haryoung","Mo, In-Pil","Lee, Ok-Jun","Webby, Richard J","Jung, Jae U","Choi, Young Ki"],"date":"2020-04-08T11:00:00Z","year":2020,"_id":"32259477","week":"202015|Apr 06 - Apr 12","doi":"10.1016/j.chom.2020.03.023","keywords":["2019-ncov","2019-novel coronavirus","covid-19","sars-cov-2","ferrets","novel coronavirus disease","severe acute respiratory syndrome coronavirus 2","transmission","virus shedding"],"source":"PubMed","topics":["Diagnosis","Transmission"],"weight":1,"locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640769731854336,"score":124.59812},{"pmid":32091395,"pmcid":"PMC7060038","title":"Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19.","text":["Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19.","Traveller screening is being used to limit further spread of COVID-19 following its recent emergence, and symptom screening has become a ubiquitous tool in the global response. Previously, we developed a mathematical model to understand factors governing the effectiveness of traveller screening to prevent spread of emerging pathogens (Gostic et al., 2015). Here, we estimate the impact of different screening programs given current knowledge of key COVID-19 life history and epidemiological parameters. Even under best-case assumptions, we estimate that screening will miss more than half of infected people. Breaking down the factors leading to screening successes and failures, we find that most cases missed by screening are fundamentally undetectable, because they have not yet developed symptoms and are unaware they were exposed. Our work underscores the need for measures to limit transmission by individuals who become ill after being missed by a screening program. These findings can support evidence-based policy to combat the spread of COVID-19, and prospective planning to mitigate future emerging pathogens.","Elife","Gostic, Katelyn","Gomez, Ana Cr","Mummah, Riley O","Kucharski, Adam J","Lloyd-Smith, James O","32091395"],"abstract":["Traveller screening is being used to limit further spread of COVID-19 following its recent emergence, and symptom screening has become a ubiquitous tool in the global response. Previously, we developed a mathematical model to understand factors governing the effectiveness of traveller screening to prevent spread of emerging pathogens (Gostic et al., 2015). Here, we estimate the impact of different screening programs given current knowledge of key COVID-19 life history and epidemiological parameters. Even under best-case assumptions, we estimate that screening will miss more than half of infected people. Breaking down the factors leading to screening successes and failures, we find that most cases missed by screening are fundamentally undetectable, because they have not yet developed symptoms and are unaware they were exposed. Our work underscores the need for measures to limit transmission by individuals who become ill after being missed by a screening program. These findings can support evidence-based policy to combat the spread of COVID-19, and prospective planning to mitigate future emerging pathogens."],"journal":"Elife","authors":["Gostic, Katelyn","Gomez, Ana Cr","Mummah, Riley O","Kucharski, Adam J","Lloyd-Smith, James O"],"date":"2020-02-25T11:00:00Z","year":2020,"_id":"32091395","week":"20209|Feb 24 - Mar 01","doi":"10.7554/eLife.55570","keywords":["covid-19","sars-cov-2","emerging infectious disease","epidemic containment","epidemic control","epidemiology","global health","human","travel screening","virus"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"_version_":1664640875185045504,"score":115.85526},{"pmid":32019669,"pmcid":"PMC7001239","title":"Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020.","text":["Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020.","Since December 2019, China has been experiencing a large outbreak of a novel coronavirus (2019-nCoV) which can cause respiratory disease and severe pneumonia. We estimated the basic reproduction number R0 of 2019-nCoV to be around 2.2 (90% high density interval: 1.4-3.8), indicating the potential for sustained human-to-human transmission. Transmission characteristics appear to be of similar magnitude to severe acute respiratory syndrome-related coronavirus (SARS-CoV) and pandemic influenza, indicating a risk of global spread.","Euro Surveill","Riou, Julien","Althaus, Christian L","32019669"],"abstract":["Since December 2019, China has been experiencing a large outbreak of a novel coronavirus (2019-nCoV) which can cause respiratory disease and severe pneumonia. We estimated the basic reproduction number R0 of 2019-nCoV to be around 2.2 (90% high density interval: 1.4-3.8), indicating the potential for sustained human-to-human transmission. Transmission characteristics appear to be of similar magnitude to severe acute respiratory syndrome-related coronavirus (SARS-CoV) and pandemic influenza, indicating a risk of global spread."],"journal":"Euro Surveill","authors":["Riou, Julien","Althaus, Christian L"],"date":"2020-02-06T11:00:00Z","year":2020,"_id":"32019669","week":"20206|Feb 03 - Feb 09","doi":"10.2807/1560-7917.ES.2020.25.4.2000058","keywords":["2019-ncov","wuhan","coronavirus","emerging infectious disease","mathematical modelling"],"link_erratum_in":"32098643","source":"PubMed","topics":["Transmission"],"weight":1,"locations":["China","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640875379032064,"score":104.10189},{"pmid":32328367,"pmcid":"PMC7170025","title":"Coronavirus (COVID-19): A Review of Clinical Features, Diagnosis, and Treatment.","text":["Coronavirus (COVID-19): A Review of Clinical Features, Diagnosis, and Treatment.","Coronavirus (COVID-19) is an enveloped RNA virus that is diversely found in humans and wildlife. A total of six species have been identified to cause disease in humans. They are known to infect the neurological, respiratory, enteric, and hepatic systems. The past few decades have seen endemic outbreaks in the form of Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome related coronavirus (SARS-CoV). Yet again, we see the emergence of another outbreak due to a new strain called the SARS-CoV-2 virus. The most recent outbreak initially presented as pneumonia of unknown etiology in a cluster of patients in Wuhan, China. The epicenter of infection was linked to seafood and exotic animal wholesale markets in the city. SARS-CoV-2 is highly contagious and has resulted in a rapid pandemic of COVID-19. As the number of cases continues to rise, it is clear that these viruses pose a threat to public health. This review will introduce a general overview of coronavirus and describe the clinical features, evaluation, and treatment of COVID-19 patients. It will also provide a means to raise awareness among primary and secondary healthcare providers during the current pandemic. Furthermore, our review focuses on the most up-to-date clinical information for the effective management, prevention, and counseling of patients worldwide.","Cureus","Hassan, Syed Adeel","Sheikh, Fahad N","Jamal, Somia","Ezeh, Jude K","Akhtar, Ali","32328367"],"abstract":["Coronavirus (COVID-19) is an enveloped RNA virus that is diversely found in humans and wildlife. A total of six species have been identified to cause disease in humans. They are known to infect the neurological, respiratory, enteric, and hepatic systems. The past few decades have seen endemic outbreaks in the form of Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome related coronavirus (SARS-CoV). Yet again, we see the emergence of another outbreak due to a new strain called the SARS-CoV-2 virus. The most recent outbreak initially presented as pneumonia of unknown etiology in a cluster of patients in Wuhan, China. The epicenter of infection was linked to seafood and exotic animal wholesale markets in the city. SARS-CoV-2 is highly contagious and has resulted in a rapid pandemic of COVID-19. As the number of cases continues to rise, it is clear that these viruses pose a threat to public health. This review will introduce a general overview of coronavirus and describe the clinical features, evaluation, and treatment of COVID-19 patients. It will also provide a means to raise awareness among primary and secondary healthcare providers during the current pandemic. Furthermore, our review focuses on the most up-to-date clinical information for the effective management, prevention, and counseling of patients worldwide."],"journal":"Cureus","authors":["Hassan, Syed Adeel","Sheikh, Fahad N","Jamal, Somia","Ezeh, Jude K","Akhtar, Ali"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32328367","week":"202017|Apr 20 - Apr 26","doi":"10.7759/cureus.7355","keywords":["clinical features","coronavirus","cough","covid-19","diagnosis","dyspnea","pathogenesis","rna virus","sars-cov-2","zoonoses"],"source":"PubMed","topics":["Treatment","Diagnosis"],"weight":1,"locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664996914727223296,"score":87.887856},{"pmid":32330293,"title":"Persistent viral RNA positivity during recovery period of a patient with SARS-CoV-2 infection.","text":["Persistent viral RNA positivity during recovery period of a patient with SARS-CoV-2 infection.","As an emerging infectious disease, the clinical course and virological course of SARS-CoV-2 infection remain to be further investigated. In this case report, we described a case of SARS-CoV-2 infection with clinical course more than two months. This patient had recovered from the pneumonia after treatment. The viral RNA of throat swabs became negative and the viral specific antibodies were produced during recovery period. However, the viral RNA reappeared and additionally persisted in throat swabs for more than 40 days. In addition, the viral RNA was detected in multiple types of specimens with extremely high titers in the saliva. In conclusion, these findings indicate that SARS-CoV-2 can cause a long clinical course. The coexistence of viral RNA and viral specific antibodies may imply an immune evasion of SARAS-CoV-2 from host's immune system. This article is protected by copyright. All rights reserved.","J Med Virol","Yang, Jian-Rong","Deng, Dao-Ting","Wu, Nan","Yang, Bin","Li, Hong-Juan","Pan, Xiao-Ben","32330293"],"abstract":["As an emerging infectious disease, the clinical course and virological course of SARS-CoV-2 infection remain to be further investigated. In this case report, we described a case of SARS-CoV-2 infection with clinical course more than two months. This patient had recovered from the pneumonia after treatment. The viral RNA of throat swabs became negative and the viral specific antibodies were produced during recovery period. However, the viral RNA reappeared and additionally persisted in throat swabs for more than 40 days. In addition, the viral RNA was detected in multiple types of specimens with extremely high titers in the saliva. In conclusion, these findings indicate that SARS-CoV-2 can cause a long clinical course. The coexistence of viral RNA and viral specific antibodies may imply an immune evasion of SARAS-CoV-2 from host's immune system. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Yang, Jian-Rong","Deng, Dao-Ting","Wu, Nan","Yang, Bin","Li, Hong-Juan","Pan, Xiao-Ben"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330293","week":"202017|Apr 20 - Apr 26","doi":"10.1002/jmv.25940","keywords":["coronavirus","sars-cov-2","saliva","virus shedding"],"source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1664996914958958594,"score":69.58819}]}